Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception

NCT: NCT03067272 · COMPLETED

NCT IDNCT03067272
StatusCOMPLETED
Start Date2017-03-15
Completion2023-03-14
SponsorFemasys Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Prospective, multi-center, pilot study evaluating the safety of the FemBloc® Permanent Contraceptive System for female sterilization in preventing pregnancy.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑